Recent Advances in Understanding and Managing Tourette Syndrome [version 1; referees: 3 approved]
Tourette syndrome (TS) is a neurologic and behavioral disorder consisting of motor and phonic tics with onset in childhood or adolescence. The severity of tics can range from barely perceptible to severely impairing due to social embarrassment ...
Mary Ann Thenganatt, Joseph Jankovic
doaj +1 more source
The MPTT‐nanozyme‐hydrogel system (Mn3O4@ChS‐HA) provides a multifunctional therapeutic strategy for intervertebral disc degeneration (IVDD), effectively targeting oxidative stress and enhancing AF repair by restoring extracellular matrix (ECM) and redox homeostasis.
Yangyang Chen+13 more
wiley +1 more source
Botulinum Toxin for the Treatment of Hand Tremor
The aim of this study is to review our longitudinal experience with onabotulinumtoxinA (onaBoNT-A) injections for medically refractory hand tremor. We performed a retrospective review of our database of patients treated with onaBoNT-A for hand tremor ...
Nicki Niemann, Joseph Jankovic
doaj +1 more source
Additional file 10: of Blood transcriptomics of drug-naĂŻve sporadic Parkinsonâ s disease patients
List of common genes between A9 DA neurons of the SN in the mouse and differentially expressed transcripts in the blood of PD patients according to SAM (a) and PUMA (b). (PDF 3122 kb)
Calligaris, Raffaella+17 more
openaire +1 more source
Intraoral Drug Delivery: Bridging the Gap Between Academic Research and Industrial Innovations
Intraoral drug delivery offers a promising route for systemic and localized therapies, yet challenges such as enzymatic degradation, limited permeability, and microbial interactions hinder efficacy. This figure highlights innovative strategies—mucoadhesive materials, enzyme inhibitors, and permeation enhancers—to overcome these barriers.
Soheil Haddadzadegan+4 more
wiley +1 more source
Immunogenicity Associated with Botulinum Toxin Treatment
Botulinum toxin (BoNT) has been used for the treatment of a variety of neurologic, medical and cosmetic conditions. Two serotypes, type A (BoNT-A) and type B (BoNT-B), are currently in clinical use. While considered safe and effective, their use has been
Steven Bellows, Joseph Jankovic
doaj +1 more source
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
To update evidence‐based medicine recommendations for treating nonmotor symptoms in Parkinson's disease (PD).
K. Seppi+14 more
semanticscholar +1 more source
A Novel Approach to Implementing Artificial Thalamic Neurons with Ferroelectric Transistors
Artificial neurons created using CMOS technology often require a large number of transistors and capacitors. This study introduces an artificial thalamic neuron that employs only five CMOS compatible ferroelectric transistors. The manufactured thalamic neuron demonstrates leaky integrate‐and‐fire‐or‐burst (LIFB) functionalities, featuring self ...
Andreas Grenmyr+7 more
wiley +1 more source
Additional file 4: of Blood transcriptomics of drug-naĂŻve sporadic Parkinsonâ s disease patients
Square of the Mahalanobis distance calculated for each sample from both control and pathological class models. (PDF 3122 kb)
Calligaris, Raffaella+17 more
openaire +1 more source
Computer-Aided Diagnosis of Speech Disorder Signal in Parkinson’s Disease
Computer-aided diagnosis (CAD) can be used as a decision support system by physicians in the diagnosis and treatmentof disordered speech especially those who specialize in neurophysiology diseases. Parkinson's disease (PD) is aprogressive disorder of the nervous system that affects movement.
Heba M. Afify, Basma Ahmed
openaire +3 more sources